Researchers at various sites across the globe are conducting the FENhance study to see if an investigational study drug can be a safe and effective treatment option for relapsing multiple sclerosis.

The FENhance study is assessing how safe and effective the investigational study drug is in treating RMS, compared to an approved comparator drug that is already being used to treat patients with RMS

Among other things, participants must be:
 

• aged between 18 and 55,
• diagnosed with RMS,
• able to complete MRI, and
• willing to complete onsite clinic visit.

If you are interested in learning more about the study and see if you may qualify to participate, please complete this online pre-screener. If your answers indicate you may be eligible, you will be given the opportunity to contact a clinic site near you to learn more about the study.

For more details on the FENhance study, visit the fenstudies.com website or call 888-662-6728.